OpGen, Inc. (NASDAQ:OPGN – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $4.80 and traded as low as $4.25. OpGen shares last traded at $4.87, with a volume of 11,370 shares traded.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen initiated coverage on OpGen in a research report on Tuesday, May 20th. They issued a “sell” rating on the stock.
View Our Latest Stock Analysis on OPGN
OpGen Price Performance
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Read More
- Five stocks we like better than OpGen
- Investing in Commodities: What Are They? How to Invest in Them
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- Differences Between Momentum Investing and Long Term Investing
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- Best Stocks Under $10.00
- ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
